<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="80534">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01812447</url>
  </required_header>
  <id_info>
    <org_study_id>CPR-03434</org_study_id>
    <nct_id>NCT01812447</nct_id>
  </id_info>
  <brief_title>Evaluation of the IBV® Valve for Emphysema to Improve Lung Function</brief_title>
  <acronym>EMPROVE</acronym>
  <official_title>A Prospective, Randomized, Controlled Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Single Lobe Treatment of Severe Emphysema</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Spiration, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Spiration, Inc.</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a multicenter, prospective, randomized, controlled study designed to evaluate
      improvement of lung function after treatment with the IBV Valve System as compared to
      medical management in the control group. The control group will be evaluated in the same
      manner as the treatment group.

      The IBV Valve is a small, umbrella-shaped, one-way valve that is placed inside the airways
      of one lung. It is used to redirect air from the less healthy to the more healthy parts of
      the lung. This helps to reduce over-inflation and may improve overall lung function and
      quality of life for people living with emphysema.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2013</start_date>
  <primary_completion_date type="Anticipated">September 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Change in Forced Expiratory Volume in 1 second (FEV1)</measure>
    <time_frame>Baseline and 6 Months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Health Status as measured by St. George's Respiratory Questionnaire (SGRQ)</measure>
    <time_frame>Baseline and 6 Months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dyspnea as measured by Modified Medical Research Council Questionnaire (mMRC)</measure>
    <time_frame>Baseline and 6 Months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Exercise capacity as measured by Six Minute Walk Test (6MWT)</measure>
    <time_frame>Baseline and 6 Months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Incidence of thoracic SAEs</measure>
    <time_frame>Baseline and 6 months</time_frame>
    <safety_issue>Yes</safety_issue>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">270</enrollment>
  <condition>Emphysema</condition>
  <arm_group>
    <arm_group_label>Treatment with IBV Valve System</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects assigned to the treatment group will undergo a bronchoscopic procedure to have valves placed in the most diseased lobe of the lung to occlude all segments of the lobe. Subjects assigned to this group will also receive medical management.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Medical Management</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The control group for this study will receive medical management.  This medical management group will be evaluated and followed in the same manner as the treatment group, but without having a bronchoscopic procedure.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>IBV Valve System</intervention_name>
    <description>Subjects assigned to the treatment group will undergo a bronchoscopic procedure to have valves placed in the most diseased lobe of the lung to occlude all segments of the lobe.</description>
    <arm_group_label>Treatment with IBV Valve System</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Medical Management</intervention_name>
    <description>Stable management is based on the ACP/ACCP/ATS/ERS Guidelines for Management of Stable COPD. Medical management will include management of COPD medications, oxygen use, and pulmonary rehabilitation.</description>
    <arm_group_label>Treatment with IBV Valve System</arm_group_label>
    <arm_group_label>Medical Management</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject has severe and heterogeneous emphysema with severe dyspnea

          -  Subject certified to meet the criteria of ATS/ERS guidelines for management of stable
             COPD

          -  Subject must be able to demonstrate physical ability to participate in the study by
             performing a 6-minute walk distance of ≥ 140 m

          -  Subject has abstained from cigarette smoking for 4 months and is willing to abstain
             throughout the study

          -  Pulmonary Function Testing Results (PFT's) demonstrate:

               -  FEV1 ≤ 45% of predicted

               -  RV ≥ 150% of predicted

               -  TLC ≥ 100% of predicted

        Exclusion Criteria:

          -  Patient has a BMI &lt; 15 kg/m2 or &gt; 35 kg/m2

          -  Arterial Blood Gas Level (ABG) indicates:

               -  PCO2 &gt; 50 mm Hg

               -  PO2 &lt; 45 mm Hg on room air

          -  Subject has a diffuse emphysema pattern or α1-antitrypsin deficiency

          -  Subject has bronchitis with sputum production &gt; 4 Tablespoons or 60 ml per day

          -  Subject has an active asthma (&gt;15 mg of prednisone daily)

          -  Giant bulla (&gt; 1/3 volume of lung)

          -  Pulmonary hypertension

          -  Subject with prior major lung surgery or recent hospitalization for COPD exacerbation
             or respiratory infections
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of California at Los Angeles Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Milan Patel</last_name>
      <phone>310-825-2517</phone>
    </contact>
    <investigator>
      <last_name>Christopher Cooper, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente Riverside Medical Center</name>
      <address>
        <city>Riverside</city>
        <state>California</state>
        <zip>92505</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erika Britton</last_name>
      <phone>951-353-5801</phone>
      <phone_ext>258</phone_ext>
    </contact>
    <investigator>
      <last_name>Greg Marrujo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ann Powers</last_name>
      <phone>619-543-2291</phone>
    </contact>
    <investigator>
      <last_name>Samir Makani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic Jacksonville</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32216</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andre McPhail</last_name>
      <phone>904-956-3213</phone>
    </contact>
    <investigator>
      <last_name>Jorge Mallea, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Florida Hospital</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32803</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathleen Summo</last_name>
      <phone>407-841-1100</phone>
      <phone_ext>225</phone_ext>
    </contact>
    <investigator>
      <last_name>Jorge Guerrero, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sarasota Memorial Hospital</name>
      <address>
        <city>Sarasota</city>
        <state>Florida</state>
        <zip>34239</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Bradley</last_name>
      <phone>941-917-6164</phone>
    </contact>
    <investigator>
      <last_name>Kirk Voelker, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Piedmont Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30309</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liz Wilkins</last_name>
      <phone>770-745-1404</phone>
      <phone_ext>6</phone_ext>
    </contact>
    <investigator>
      <last_name>Amy Case, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60561</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cyndy Warnes, RN, BSN</last_name>
      <phone>773-834-8874</phone>
    </contact>
    <investigator>
      <last_name>Kyle Hogarth, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Maryland</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Davis</last_name>
      <phone>410-328-1473</phone>
    </contact>
    <investigator>
      <last_name>Ashutosh Sachdeva, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aisha Aloma</last_name>
      <phone>617-632-8386</phone>
    </contact>
    <investigator>
      <last_name>Adnan Majid, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lahey Clinic</name>
      <address>
        <city>Burlington</city>
        <state>Massachusetts</state>
        <zip>01805</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joyce Pelletier</last_name>
      <phone>781-744-3706</phone>
    </contact>
    <investigator>
      <last_name>Carla Lamb, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Carolinas Medical Center</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessica Kearney-Bryan</last_name>
      <phone>704-355-0244</phone>
    </contact>
    <investigator>
      <last_name>Michael Zgoda, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Cincinnati</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45219</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa Banuelos</last_name>
      <phone>513-558-2187</phone>
    </contact>
    <investigator>
      <last_name>Sadia Benzaquen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente Northwest Medical Center</name>
      <address>
        <city>Clackamas</city>
        <state>Oregon</state>
        <zip>97015</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christina Carlson</last_name>
      <phone>503-571-6181</phone>
    </contact>
    <investigator>
      <last_name>Richard Mularski, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Penn State Milton S. Hershey Medical Center</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>MaryCatherine Hess</last_name>
      <phone>717-531-6010</phone>
    </contact>
    <contact_backup>
      <last_name>Terry Novchich</last_name>
      <phone>(717) 531-1389</phone>
    </contact_backup>
    <investigator>
      <last_name>Michael Reed, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan Metzger, MSN, RN</last_name>
      <phone>215-615-5478</phone>
    </contact>
    <investigator>
      <last_name>Andrew Haas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Tennessee Medical Center</name>
      <address>
        <city>Knoxville</city>
        <state>Tennessee</state>
        <zip>37920</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lauren Davis</last_name>
      <phone>865-305-7975</phone>
    </contact>
    <investigator>
      <last_name>Paul Branca, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UT Southwestern Medical Center at Dallas</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75235</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jackie Quivers</last_name>
      <phone>214-645-6489</phone>
    </contact>
    <investigator>
      <last_name>Muhanned Abu-Hijleh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Michael DeBakey VA Medical Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Perusich</last_name>
      <phone>713-794-7294</phone>
    </contact>
    <investigator>
      <last_name>Roberto Casal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Utah</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Judy Jensen</last_name>
      <phone>801-581-3961</phone>
    </contact>
    <investigator>
      <last_name>Chak Reddy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Virginia Commonwealth University</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23298</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amy Frayser</last_name>
      <phone>804-828-7966</phone>
    </contact>
    <investigator>
      <last_name>Ray Shepherd, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Washington</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valeria Martin</last_name>
      <phone>206-685-5157</phone>
    </contact>
    <investigator>
      <last_name>Doug Wood, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical College of Wisconsin</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Barb Alivo</last_name>
      <phone>414-955-6994</phone>
    </contact>
    <investigator>
      <last_name>Mario Gasparri, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 22, 2014</lastchanged_date>
  <firstreceived_date>March 7, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Endobronchial Valves</keyword>
  <keyword>Intrabronchial Valves</keyword>
  <keyword>Bronchial Valve</keyword>
  <keyword>Chronic Obstructive Pulmonary Disease</keyword>
  <keyword>COPD</keyword>
  <keyword>Pulmonary Disease, Chronic Obstructive</keyword>
  <keyword>Bronchoscopic Lung Volume Reduction</keyword>
  <keyword>BLVR</keyword>
  <keyword>TLVR</keyword>
  <keyword>Emphysema</keyword>
  <keyword>Pulmonary Emphysema</keyword>
  <keyword>Pathologic Process</keyword>
  <keyword>Lung Diseases</keyword>
  <keyword>Respiratory Tract Disease</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Emphysema</mesh_term>
    <mesh_term>Pulmonary Emphysema</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
